icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
2A3JpkENgKD8XZwm